Iron(II,III) oxide nanoparticle surface (Fe3O4 NP surface)

Iron(II,III) oxide nanoparticles, specifically magnetite (Fe3O4), are inorganic materials characterized by their superparamagnetic properties and high surface-to-volume ratio (Source: PubMed, PMID: 28603155). The surface of these nanoparticles is not a biological target in the traditional sense; rather, it acts as a versatile platform for functionalization with various ligands, polymers, and drugs to facilitate targeted delivery and diagnostic imaging (Source: Nanoscale Research Letters, 2018). In clinical applications, Fe3O4 nanoparticles are used as contrast agents for magnetic resonance imaging (MRI) to improve the visualization of tumors and vascular structures (Source: Wikipedia, Magnetic nanoparticles). They are also utilized as therapeutic agents in magnetic hyperthermia, where they generate localized heat under an alternating magnetic field to induce apoptosis in malignant cells (Source: NIH, National Cancer Institute). Furthermore, certain formulations like ferumoxytol are approved for the treatment of iron deficiency anemia, where the nanoparticle core provides a source of bioactive iron (Source: FDA, Feraheme Label). Despite their utility, the surface reactivity of Fe3O4 can lead to the generation of reactive oxygen species (ROS) through Fenton-like reactions, necessitating careful surface coating to mitigate toxicity and ensure biocompatibility (Source: Particle and Fibre Toxicology, 2013). The interaction between the nanoparticle surface and biological fluids often results in the formation of a protein corona, which significantly influences the particle's pharmacokinetics and cellular uptake (Source: Nature Nanotechnology, 2014). Research continues into using these surfaces for biosensing and as catalysts in various biomedical assays (Source: Journal of Materials Chemistry B, 2020).

Other names

Magnetite nanoparticle surfaceSuperparamagnetic iron oxide nanoparticle surfaceSPION surfaceFerrosoferric oxide nanoparticle surface

Enhancement of T2 relaxation in magnetic resonance imaging (MRI), conversion of magnetic energy into thermal energy for hyperthermia, and acting as a scaffold for targeted drug delivery.